0 results for 'Sanofi US Services Inc'
Supreme Court To Revisit the Patent Enablement Standard
The decision in 'Amgen v. Sanofi' has the potential to have a significant impact on inventors and patent drafters, and the breadth with which they may be able to claim their inventions.Supreme Court Will Again Be Focus of IP World in 2023
Despite having lost two of its strongest voices on IP in the last two years, the high court is wading into some 'meat and potatoes' IP issues such as pharma patents and copyright fair use.'The Human Side:' Shook Hardy Partner Exits to Lead Legal Services Group
"I've checked all the boxes on the private practice side and was really looking for a new challenge," said Matthew Keenan.A Cavalcade of Worthy Litigator of the Week Runners-Up and Shout Outs
Our first runners-up his week are litigators at Quinn Emanuel who scored key defense wins in a pair of proposed privacy class actions brought on behalf of users of Google's Chrome browser.View more book results for the query "Sanofi US Services Inc"
Federal Judge Tosses Plaintiffs Experts, Eliminating Thousands of Zantac Lawsuits
"In a products liability MDL, the plaintiff must have admissible primary evidence with which to establish general causation," said Judge Rosenberg. "The Plaintiffs fail to produce admissible primary evidence of general causation."Federal Judge Tosses Plaintiffs Experts, Eliminating Thousands of Zantac Lawsuits
U.S. District Judge Robin Rosenberg ruled that plaintiffs' experts in the Zantac multidistrict litigation had "unreliable methodologies" and "analytical leaps" from existing data.Fighting Fraud in Health Care Through the False Claims Act in the Third Circuit
The Third Circuit has adopted a more plaintiff/relator friendly interpretation while the Eighth Circuit has reached the opposite conclusion. Until the U.S. Supreme Court settles the circuit split, choice of venue is key for those bringing claims under the Anti-Kickback statute.Johnson & Johnson Tells Supreme Court 'Dangerous Trend' Led to $344M Mesh Verdict
Johnson & Johnson has petitioned the U.S. Supreme Court to reverse a $344 million transvaginal mesh verdict for the state of California in a bench trial against its Ethicon unit.Trending Stories
Unlocking the Power of Early Case Assessment Workflows
Brought to you by Integreon
Download Now
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now